Fair Value Measurement - Assets and liabilities measured at fair value on a nonrecurring basis (Details) $ in Thousands |
12 Months Ended | |||
|---|---|---|---|---|
|
Dec. 31, 2025
CNY (¥)
|
Dec. 31, 2025
USD ($)
|
Dec. 31, 2024
CNY (¥)
|
Dec. 31, 2023
CNY (¥)
|
|
| Fair Value Measurement | ||||
| Equity securities without readily determinable fair value | ¥ 140,959,000 | ¥ 51,176,000 | ¥ 44,621,000 | |
| Impairment of intangible assets | 10,460,000 | $ 1,496 | 0 | 0 |
| Impairment loss on goodwill | ¥ 126,344,000 | $ 18,067 | ¥ 0 | ¥ 0 |
| X | ||||||||||
- Definition Amount of investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|